David Levine, DO
Adult Reconstructive Orthopaedic Surgery · Rockaway, NJNPI 1548523533
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,817 of the $4,851 with a category attached, or 78.7%. 17 manufacturers reported payments, led by Zimmer Biomet at 44.5% of the total. 2025 is the largest year on record at $2,864, more than ten times the $254 reported in 2019. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in NJ, where the typical reported total is $8,051.
Across 114 payments — averaging $42.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$2K
- Stryker$1K
- Ferring Pharmaceuticals Inc.$898
- Bioventus LLC$173
- Johnson & Johnson$128
- Heraeus Medical, LLC.$93
- plus $318 from 11 others
What the payments were for
- Travel & lodging$94619%
- Food & beverage$3,81779%
- Education$882%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 16 | $2,156 |
| Stryker | 12 | $1,085 |
| Ferring Pharmaceuticals Inc. | 53 | $898 |
| Bioventus LLC | 4 | $173 |
| Johnson & Johnson | 6 | $128 |
| Heraeus Medical, LLC. | 4 | $93 |
| Amgen | 4 | $58 |
| Pacira Therapeutics, Inc. | 4 | $56 |
| Kowa Pharmaceuticals America, Inc. | 2 | $35 |
| Medtronic(2 entities) | 2 | $30 |
| Medacta USA, Inc. | 1 | $30 |
| Linkbio Corp | 1 | $29 |
| Intellijoint Surgical Inc. | 1 | $18 |
| Pfizer | 1 | $17 |
| Solventum Corporation | 1 | $16 |
| Seapearl East, Inc | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,851 in reported general payments places this provider in the 35th percentile of 39 adult reconstructive orthopaedic surgery providers in New Jersey.
See all adult reconstructive orthopaedic surgery providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 72 | $1,960 |
| Meloxicam | 118 | $868 |
| Naproxen | 82 | $327 |
| Omeprazole | 29 | $247 |
| Duloxetine Hcl | 13 | $188 |
| Methylprednisolone | 26 | $184 |
| Oxycodone Hcl | 29 | $174 |
| Cefadroxil | 32 | $174 |
| Doxycycline Hyclate | 26 | $166 |
| Amoxicillin | 85 | $134 |
| Tramadol Hcl | 36 | $107 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Rockaway
- Atul KamathManasquan$4M
- Alfred TriaSomerset$582K
- John DundonHackettstown$573K
- Ismar DizdarevicRidgewood$368K
- David FeldmanEnglewood$335K
- Mark PizzurroRidgewood$239K
- Jeffrey LearyNew Providence$148K
- Timothy HendersonWayne$140K
- Anthony CostaEatontown$95K
- Gregory RoehrigManasquan$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.